|
CHECK OUT OUR JULY 15TH ISSUE
This new glaucoma drug is the only fixed-dose combination therapy for glaucoma without a beta blocker in the United States. Read more about this IOP-lowering drug in our cover story.
» Read more
|
|
Vision loss caused by diabetic macular edema increases the health and financial burdens of managing diabetes, especially for long-haul truckers who rely on their eyesight to maintain employment. » Read more
|
|
The lesson of flight 214 for us in medicine is that we should be creating teams of people (physicians, nurses, anesthesiologists, technicians, etc.) who know each other, can anticipate what is coming next, and communicate well. » Read more
|
|
Pupils can be pharmacologically dilated after death, according to the results of a recent study. The study examined pupillary dilation of postmortem eye bank eyes, which may facilitate postmortem examination and screening through modalities such as fundus photography and fundus optical coherence tomography.
» Read more
|
|
Through improved communication and coordination with patients and other health care professionals as well as advocacy for increased or maintained funding for prevention of vision-related problems, ophthalmologists can help decrease costs associated with eye disorders and vision loss. » Read more
|
|
Human ocular tissue has a critical role in helping researchers understand and find new treatments for diseases that include glaucoma, age-related macular degeneration, and cataract.» Read more
|
|
|
Like
Tweet
